H

Hospital Regional Universitario de Malaga | Hospital Civil - Rheumatology Department

Research site
(Unclaimed)
Location
Avenida Arroyo de los Angeles S/N, Malaga, Málaga, Spain
Site insights

Top conditions

Lung Cancer (3 trials)

Acute Myeloid Leukemia (2 trials)

Small Cell Lung Carcinoma (2 trials)

Non-Small-Cell Lung Carcinoma (2 trials)

Myeloid Leukemia (2 trials)

Top treatments

Magrolimab
Azacitidine
Venetoclax
Atezolizumab
Tiragolumab
Pembrolizumab
Ruxolitinib
Sacituzumab
Evolocumab
Cenobamate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

12 of 14
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study Evaluating The Safety, Pharmacokinetics, and Efficacy Of Crovalimab Versus Eculizumab In Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors (COMMODORE 1)

A study designed to evaluate the safety of crovalimab with eculizumab in participants with PNH currently treated with complement inhibitors. This stu...

Enrolling
Paroxysmal Nocturnal Hemoglobinuria
Drug: Crovalimab
Drug: Eculizumab

This study will evaluate the efficacy, safety, and pharmacokinetics of immunotherapy-based treatment combinations in participants with metastatic non...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: XL092
Drug: Ipatasertib

The purpose of the study is to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab in participa...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Tiragolumab
Drug: Atezolizumab
Locations recently updated

The primary objectives are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis (RMS)...

Enrolling
Relapsing Forms of Multiple Sclerosis
Drug: BIIB091
Drug: DRF

The main objective of this study is to compare efficacy of bemarituzumab combined with oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) (mFOLFOX6)...

Enrolling
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Drug: Bemarituzumab
Drug: Placebo

The purpose of this study is to assess the safety and efficacy of tulisokibart in participants with SSc-ILD.

Enrolling
Diffuse Cutaneous Systemic Sclerosis
Interstitial Lung Disease
Diagnostic Test: Companion diagnostic ( CDx)
Drug: Placebo
Locations recently updated

The purpose of this study is to compare overall survival (OS) and progression free survival (PFS) per Response Evaluation Criteria in Solid Tumors Ve...

Enrolling
Small Cell Lung Cancer
Radiation: Standard Thoracic Radiotherapy
Biological: Pembrolizumab 400 mg

This trial is intended to study the safety and effectiveness of an new anti-epileptic drug (AED) on Primary Generalized Tonic-Clonic (PGTC) Seizures....

Enrolling
Primary Generalized Epilepsy
Drug: Placebo
Drug: Cenobamate

The main objective is to compare the efficacy of tarlatamab with standard of care (SOC) on prolonging overall survival (OS).

Enrolling
Small Cell Lung Cancer (SCLC)
Drug: Lurbinectedin
Drug: Topotecan

The goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of the study drug, magrolimab in combination w...

Active, not recruiting
Head and Neck Squamous Cell Carcinoma
Drug: Magrolimab
Drug: 5-FU

Myelofibrosis (MF) is a rare blood cancer, notable for scarring of the bone marrow (the spongy tissue inside bones) and the spleen becoming larger. T...

Enrolling
Myelofibrosis (MF)
Drug: Best Available Therapy (BAT)
Drug: Ruxolitinib
Locations recently updated

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large...

Enrolling
Ulcerative Colitis
Drug: Upadacitinib

Trial sponsors

Gilead Sciences logo

Gilead Sciences (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems